HAMPS BIO LIMITED Share Price
HAMPS BIO LIMITED Returns Calculator
About HAMPS BIO LIMITED
Hamps Bio Limited is an India-based company, which is engaged in pharmaceutical formulation and freeze-drying ingredient manufacturing and distributing. Its products include home pharmaceutical products and freeze-drying food products. Its home pharmaceutical products include antibiotic/antibacterial/antifungal; hematantic/calcium supplement; painkiller/ anti-inflammatory; antiacid/PPI; mouth wash; toothpaste; pediatric care; nutrition supplement, and injections. Its freeze-drying food products include ingredients for fruit tea / traditional tea; ingredients for fruit snacks / juice powder/ smoothie mix / ice cream; ingredients for noodles / instant food / ready to eat; ingredients for super food, and application like camel milk / curd / panner/ cheese / cow colostrum. Its injection products include ALLSEF; Beep 40; BMXCLAV; PTSEFT; SEFTZONE-1.5GM, and others. Its ingredients for super food include prickly pear, beet, spinach, noni, garcinia cambochia, and more.
HAMPS BIO LIMITED Financial Highlights
- Revenue: HAMPS BIO LIMITED reported revenue of ₹8.80 crore in FY26 vs ₹6.82 crore in FY25. It showed an increase of 29.03% on a yearly basis.
- Operating Profit: HAMPS BIO LIMITED reported an operating loss of ₹0.70 crore in FY26 vs ₹0.40 crore in FY25. It showed a decrease of 275.00% on a year-on-year basis.
- Net Profit: HAMPS BIO LIMITED reported a net loss of ₹0.74 crore in FY26 vs ₹0.30 crore in FY25. It showed a decrease of 346.67% on a yearly basis.
| Mar 2025 | 0.00% |
|---|---|
| Jun 2025 | 0.00% |
| Sep 2025 | 0.00% |
| Mar 2026 | 0.00% |
HAMPS BIO LIMITED Shareholder Returns
HAMPS BIO LIMITED Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,63,791.00 | 38.28 | 5.55 | 13.74% | 0.61 | 17.33% | 93.24 | 0.83% | 0.48 | 10.90 |
| Divis Laboratories | 2,45,081.00 | 83.79 | 14.62 | 15.32% | 0.00 | 19.56% | 629.49 | 0.32% | 0.55 | 98.19 |
| Torrent Pharmaceuticals | 1,90,351.00 | 88.29 | 22.64 | 25.49% | 1.69 | 13.85% | 222.76 | 0.68% | 0.49 | 58.70 |
| Zydus Lifesciences | 1,14,833.00 | 25.00 | 4.24 | 18.59% | 0.31 | 17.35% | 237.30 | 0.09% | 0.33 | 35.38 |
| Cipla | 1,14,163.00 | 34.02 | 3.32 | 11.27% | 0.00 | 14.95% | 423.36 | 0.92% | 0.45 | 43.52 |
| Laurus Labs | 1,00,660.00 | 92.32 | 18.99 | 16.77% | 0.40 | 16.14% | 97.20 | 0.11% | 0.67 | 13.72 |
| Lupin | 98,431.00 | 17.73 | 4.38 | 23.76% | 0.04 | 24.88% | 659.00 | 0.84% | 0.57 | 129.18 |
| Dr. Reddy's Laboratories | 96,906.30 | 30.44 | 2.55 | 11.07% | 0.18 | 12.54% | 377.95 | 0.69% | 0.41 | 38.68 |
| Mankind Pharma | 97,467.00 | 47.54 | 6.03 | 11.74% | 0.34 | 13.13% | 396.98 | 0.04% | 0.44 | 49.37 |
| Aurobindo Pharma | 95,299.80 | 25.68 | 2.52 | 9.25% | 0.19 | 11.76% | 394.82 | 0.24% | 0.38 | 41.58 |
HAMPS BIO LIMITED Financials
Income Statement · Consolidated
| Particulars | Mar 2026 | Mar 2025 |
|---|---|---|
| Revenue | ₹8.47 | ₹6.67 |
| Other Income | ₹0.33 | ₹0.15 |
| Total Revenue | ₹8.81 | ₹6.82 |
| Total Expenses | ₹9.51 | ₹6.42 |
| Profit Before Tax | -₹0.70 | ₹0.40 |
| Tax | ₹0.04 | ₹0.11 |
| Profit After Tax | -₹0.74 | ₹0.30 |
| EPS - Basic | -₹0.85 | ₹0.34 |
| EPS - Diluted | -₹0.85 | ₹0.34 |
Cash Flow · Consolidated
| Particulars | Mar 2026 | Mar 2025 |
|---|---|---|
| Profit before tax | -₹0.74 | ₹0.30 |
| Income before WC changes | ₹0.30 | -₹0.19 |
| Change in Assets | -₹0.92 | -₹1.77 |
| Change in Liabilities | -₹0.09 | ₹0.30 |
| Change in WC | -₹1.01 | -₹1.47 |
| Cash flow from Operations | -₹0.71 | -₹1.76 |
| Cash flow from Investing | -₹2.93 | -₹6.21 |
| Cash flow from Financing | ₹3.72 | ₹8.00 |
| Total Cash Flow | ₹0.07 | ₹0.04 |
| Cash (Start of the year) | ₹0.10 | ₹0.06 |
| Cash (End of the year) | ₹0.17 | ₹0.10 |
Balance Sheet · Consolidated
| Particulars | Mar 2026 | Mar 2025 |
|---|---|---|
| Non-Current Assets | ₹10.62 | ₹8.49 |
| Current Assets | ₹5.30 | ₹4.31 |
| Total Assets | ₹15.92 | ₹12.79 |
| Current Liabilities | ₹3.62 | ₹1.87 |
| Net Current Asset | ₹1.68 | ₹2.43 |
| Non-Current Liabilities | ₹4.20 | ₹2.12 |
| Equity Capital | ₹8.10 | ₹8.80 |
| Total Equity & Liabilities | ₹15.92 | ₹12.79 |
Income Statement · Standalone
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | ₹8.52 | ₹6.67 | ₹6.48 | ₹5.58 |
| Other Income | ₹0.33 | ₹0.15 | ₹0.03 | ₹0.01 |
| Total Revenue | ₹8.85 | ₹6.82 | ₹6.50 | ₹5.58 |
| Total Expenses | ₹9.47 | ₹6.42 | ₹5.85 | ₹5.23 |
| Profit Before Tax | -₹0.62 | ₹0.40 | ₹0.65 | ₹0.36 |
| Tax | ₹0.04 | ₹0.11 | ₹0.15 | ₹0.00 |
| Profit After Tax | -₹0.65 | ₹0.30 | ₹0.50 | ₹0.36 |
| EPS - Basic | -₹0.75 | ₹0.34 | ₹2.55 | ₹1.34 |
| EPS - Diluted | -₹0.75 | ₹0.34 | ₹2.55 | ₹1.34 |
Cash Flow · Standalone
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Profit before tax | -₹0.65 | ₹0.30 | ₹0.50 | ₹0.36 |
| Income before WC changes | ₹0.39 | -₹0.19 | ₹1.15 | ₹0.87 |
| Change in Assets | -₹0.37 | -₹1.77 | -₹1.21 | ₹0.10 |
| Change in Liabilities | -₹0.39 | ₹0.30 | -₹0.08 | ₹0.26 |
| Change in WC | -₹0.76 | -₹1.47 | -₹1.29 | ₹0.36 |
| Cash flow from Operations | -₹0.37 | -₹1.76 | -₹0.29 | ₹1.23 |
| Cash flow from Investing | -₹2.93 | -₹6.21 | -₹0.37 | -₹0.75 |
| Cash flow from Financing | ₹3.23 | ₹8.00 | ₹0.67 | -₹0.48 |
| Total Cash Flow | -₹0.06 | ₹0.04 | ₹0.01 | ₹0.00 |
| Cash (Start of the year) | ₹0.10 | ₹0.06 | ₹0.05 | ₹0.05 |
| Cash (End of the year) | ₹0.03 | ₹0.10 | ₹0.06 | ₹0.05 |
Balance Sheet · Standalone
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Non-Current Assets | ₹10.61 | ₹8.49 | ₹2.68 | ₹2.73 |
| Current Assets | ₹4.62 | ₹4.31 | ₹2.44 | ₹1.23 |
| Total Assets | ₹15.22 | ₹12.79 | ₹5.12 | ₹3.96 |
| Current Liabilities | ₹3.17 | ₹1.87 | ₹1.40 | ₹2.07 |
| Net Current Asset | ₹1.44 | ₹2.43 | ₹1.03 | -₹0.84 |
| Non-Current Liabilities | ₹3.87 | ₹2.12 | ₹0.37 | ₹0.52 |
| Equity Capital | ₹8.18 | ₹8.80 | ₹3.34 | ₹1.36 |
| Total Equity & Liabilities | ₹15.22 | ₹12.79 | ₹5.12 | ₹3.96 |
| 1 Sep | 0L |
|---|---|
| Average | 0L |
Popular Stocks
HAMPS BIO LIMITED Share Price FAQs
What is HAMPS BIO LIMITED share price today?
HAMPS BIO LIMITED share price is ₹25.90 as on 01 Sep, 2026, 15:28 IST.
How much is the Mutual Fund shareholding in HAMPS BIO LIMITED shares?
The Mutual Fund Shareholding in HAMPS BIO LIMITED was 0.00% at the end of Mar 2026.
What is the the 52-week high and low of HAMPS BIO LIMITED shares ?
The 52-week high and low of HAMPS BIO LIMITED share is ₹30.00 and ₹13.36 as of 01 Sep, 2026.
What is the market cap of HAMPS BIO LIMITED?
The market capitalisation of HAMPS BIO LIMITED is ₹0.00 Crores as on 01 Sep, 2026.
What are the stock symbols of HAMPS BIO LIMITED?
The stock symbol of HAMPS BIO LIMITED is 544312 on the BSE, and the ISIN is INE0QBD01018.
How to buy HAMPS BIO LIMITED shares?
To buy HAMPS BIO LIMITED shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
What was yesterday's closing price for HAMPS BIO LIMITED shares ?
HAMPS BIO LIMITED shares closed yesterday at ₹25.90 on BSE
Can I buy HAMPS BIO LIMITED shares on Holidays?
No, shares of HAMPS BIO LIMITED or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell HAMPS BIO LIMITED shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.